Sanara MedTech Inc. (SMTI)

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close

35.15 on 12 Oct 2026

0 buys0 sales at will0 planned sales

Key numbers

Fiscal year 2025, ended 31 Dec 2025, as filed

Revenue

$103.12M

Net income

$37.56M

Free cash flow

$2.16M

Gross margin

92.7%

Operating margin

7.1%

Net margin

-36.4%

Return on equity

-632.5%

Return on capital

10.9%

Debt to equity

7.90

Revenue growth, 1 yr

19.0%

Revenue growth, 5 yr

45.9% a year

Revenue and profit

Fiscal years, as filed with the SEC · point at a year for the detail

Full statements →

RevenueNet incomeLoss

Latest insider transactions

From Form 4, most recent first

All of them →

Date	Insider	Type	Value	Of own stake
8 Nov 2022	Fleming Zachary B. Chief Executive Officer	Sold, plan not stated	$13.76K	1.1%
4 Nov 2022	Fleming Zachary B. Chief Executive Officer	Sold, plan not stated	$18.58K	1.5%
2 Nov 2022	Fleming Zachary B. Chief Executive Officer	Sold, plan not stated	$660.40	0.1%
22 Sep 2022	Bowman Shawn M. Pres. - Strategic Partnerships	Sold, plan not stated	$27.89K	5.1%
6 Jul 2022	Fleming Zachary B. Chief Executive Officer	Sold, plan not stated	$31.88K	3.7%
5 Jul 2022	Fleming Zachary B. Chief Executive Officer	Sold, plan not stated	$5.68K	0.7%

Clue Score

How it works

48out of 100

Profitability 23

Financial strength 23

Growth 100

Insiders 50

Strongest on growth (100), weakest on financial strength (23). A score of the business, not of the price.

What insiders did

Last 12 months

Only here

Bought

$0.00

0 buys, 0 buyers

Sold

$0.00

0 sales

Planned sales

n/a

under a 10b5-1 plan

Every insider, every trade →

Profile

Sector: Health care
Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies
Country: United States
SEC filings: EDGAR →